Investor Relations

CO.DON AG stands for open, dependable communications with shareholders,  financial analysts and media. By providing transparent, timely information we create a positive foundation for developing a trusted relationship with the financial community.

Why not find out about our company's rapid development and ambitious targets? As a shareholder you too will benefit from the positive long-term  performance of our market capitalisation.

We are happy to answer your questions on our corporate development and can provide you with further relevant information.

05 November 2018 - CO.DON share: Sphene Capital GMBH confirms buy recommendation and target price for CO.DON share

The Munich research house Sphene Capital GmbH has confirmed its buy recommendation and price target of EUR 9.60 per share after announcing the conversion of most clinics in Germany to the EU-wide authorized CO.DON product.

The complete update of the research study (German Language) can be found here

03 September 2018 - CO.DON share: WARBURG RESEARCH GmbH confirms buy recommendation and target price for CO.DON share

The Hamburg-based equity research company WARBURG RESEARCH GmbH has confirmed its buy recommendation and the target price of € 11.50 per share following the announcement of the half-year figures for the first half of 2018 and the latest corporate news.

The full update to the research study is available here